The third Learning Collaborative discussion took place on January 21. The goal of this call was to discuss the options for financing RSV vaccine in birthing centers from research conducted by the Camden Coalition. This ongoing collaboration aims to increase the capacity of jurisdictions to equitably protect infants from serious illness and death due to RSV. Through understanding the challenges to birthing hospital participation in the Vaccines for Children (VFC) program and sharing promising practices, the collaborative hopes to increase birthing hospital participation in the VFC program and help to ensure that every newborn has the opportunity to be protected from RSV disease.
Learning Collaborative Call January 21, 2025
Related Resources
2025-2026 Respiratory Syncytial Virus (RSV) Monoclonal Antibody (mAb) Season Extension Map
The AIM RSV Season Extension Map provides a national snapshot of how the 66 federally funded immunization programs are responding to recent increases in RSV cases.
Request for Interest Forms: Community of Practice to Optimize Infant Protection Against RSV
AIM invites interested parties to participate in its Immunization Program and Birthing Institution Community of Practice to Optimize Infant Protection Against RSV.
Learning Collaborative
AIM, in collaboration with the CDC, has launched a Learning Collaborative to increase the capacity of jurisdictions to equitably protect infants from RSV.